Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?

Objectives: Psoriasis is a chronic inflammatory skin disease. Chronic inflammation results in increased oxidative stress and oxidizes lipoproteins, increasing their atherogenicity. This study sought to estimate the levels of oxidized low-density lipoprotein (ox-LDL) and antibodies against oxidized L...

Full description

Bibliographic Details
Main Authors: Medha Rajappa, Devinder Mohan Thappa, Laxmisha Chandrashekar, Malathi Munisamy, G. Revathy
Format: Article
Language:English
Published: Oman Medical Specialty Board 2016-09-01
Series:Oman Medical Journal
Subjects:
Online Access:http://omjournal.org/articleDetails.aspx?coType=1&aId=1818
_version_ 1828484268589842432
author Medha Rajappa
Devinder Mohan Thappa
Laxmisha Chandrashekar
Malathi Munisamy
G. Revathy
author_facet Medha Rajappa
Devinder Mohan Thappa
Laxmisha Chandrashekar
Malathi Munisamy
G. Revathy
author_sort Medha Rajappa
collection DOAJ
description Objectives: Psoriasis is a chronic inflammatory skin disease. Chronic inflammation results in increased oxidative stress and oxidizes lipoproteins, increasing their atherogenicity. This study sought to estimate the levels of oxidized low-density lipoprotein (ox-LDL) and antibodies against oxidized LDL (anti-ox-LDL) and compute the ratio of anti-ox-LDL/ox-LDL as a single composite parameter to assess the oxidative lipoprotein burden as an indicator of cardiovascular risk in patients with psoriasis. Methods: This cross-sectional study included 45 patients with psoriasis. All patients were given a psoriasis severity index score and their ox-LDL and anti-ox-LDL estimated using ELISA. Results: The results of this study show an elevation in the ratio of anti-ox-LDL to ox-LDL in patients with psoriasis, which initiate and perpetuate the pathogenesis of psoriasis and its comorbidity, atherosclerotic cardiovascular disease. Conclusions: Our results suggest that an elevated ratio of anti-ox-LDL/ox-LDL can serve as a composite parameter reflecting the total oxidative lipoprotein burden and cardiovascular risk in psoriasis patients.
first_indexed 2024-12-11T08:52:57Z
format Article
id doaj.art-9111560ceb5b4560a80cb394ae45f3b1
institution Directory Open Access Journal
issn 1999-768X
2070-5204
language English
last_indexed 2024-12-11T08:52:57Z
publishDate 2016-09-01
publisher Oman Medical Specialty Board
record_format Article
series Oman Medical Journal
spelling doaj.art-9111560ceb5b4560a80cb394ae45f3b12022-12-22T01:13:58ZengOman Medical Specialty BoardOman Medical Journal1999-768X2070-52042016-09-01315390393Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?Medha Rajappa0Devinder Mohan Thappa1Laxmisha Chandrashekar2Malathi Munisamy3G. Revathy4Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, IndiaDepartment of Dermatology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, IndiaDepartment of Dermatology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, IndiaDepartment of Dermatology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, IndiaDepartment of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, IndiaObjectives: Psoriasis is a chronic inflammatory skin disease. Chronic inflammation results in increased oxidative stress and oxidizes lipoproteins, increasing their atherogenicity. This study sought to estimate the levels of oxidized low-density lipoprotein (ox-LDL) and antibodies against oxidized LDL (anti-ox-LDL) and compute the ratio of anti-ox-LDL/ox-LDL as a single composite parameter to assess the oxidative lipoprotein burden as an indicator of cardiovascular risk in patients with psoriasis. Methods: This cross-sectional study included 45 patients with psoriasis. All patients were given a psoriasis severity index score and their ox-LDL and anti-ox-LDL estimated using ELISA. Results: The results of this study show an elevation in the ratio of anti-ox-LDL to ox-LDL in patients with psoriasis, which initiate and perpetuate the pathogenesis of psoriasis and its comorbidity, atherosclerotic cardiovascular disease. Conclusions: Our results suggest that an elevated ratio of anti-ox-LDL/ox-LDL can serve as a composite parameter reflecting the total oxidative lipoprotein burden and cardiovascular risk in psoriasis patients.http://omjournal.org/articleDetails.aspx?coType=1&aId=1818PsoriasisOxidized Low Density Lipoprotein; Oxidative Stress; Cardiovascular DiseaseOxidized Low Density LipoproteinOxidative StressCardiovascular Disease
spellingShingle Medha Rajappa
Devinder Mohan Thappa
Laxmisha Chandrashekar
Malathi Munisamy
G. Revathy
Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?
Oman Medical Journal
Psoriasis
Oxidized Low Density Lipoprotein; Oxidative Stress; Cardiovascular Disease
Oxidized Low Density Lipoprotein
Oxidative Stress
Cardiovascular Disease
title Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?
title_full Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?
title_fullStr Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?
title_full_unstemmed Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?
title_short Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?
title_sort is the ratio of antibodies against oxidized ldl to oxidized ldl an indicator of cardiovascular risk in psoriasis
topic Psoriasis
Oxidized Low Density Lipoprotein; Oxidative Stress; Cardiovascular Disease
Oxidized Low Density Lipoprotein
Oxidative Stress
Cardiovascular Disease
url http://omjournal.org/articleDetails.aspx?coType=1&aId=1818
work_keys_str_mv AT medharajappa istheratioofantibodiesagainstoxidizedldltooxidizedldlanindicatorofcardiovascularriskinpsoriasis
AT devindermohanthappa istheratioofantibodiesagainstoxidizedldltooxidizedldlanindicatorofcardiovascularriskinpsoriasis
AT laxmishachandrashekar istheratioofantibodiesagainstoxidizedldltooxidizedldlanindicatorofcardiovascularriskinpsoriasis
AT malathimunisamy istheratioofantibodiesagainstoxidizedldltooxidizedldlanindicatorofcardiovascularriskinpsoriasis
AT grevathy istheratioofantibodiesagainstoxidizedldltooxidizedldlanindicatorofcardiovascularriskinpsoriasis